Investing.com -- Atossa Therapeutics Inc (NASDAQ: ATOS) stock surged 11.4% premarket following positive feedback from the U.S. Food and Drug Administration (FDA) regarding the company’s proposed dose ...

Avant Technologies Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an emerging technology company developing healthcare ...

Avant Technologies Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an emerging technology company developing healthcare solutions, and its Joint Venture partner, Ainnova Tech, Inc. (Ainnova), a leading ...

Investing.com -- Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) stock surged 12% after the U.S. Food and Drug Administration (FDA) approved EMPAVELI® (pegcetacoplan) as the first treatment for C3 ...

While colleges across the nation are adapting their curricula to harness the power of generative AI, U.S. medical schools remain dangerously behind.

Stock of Sarepta Therapeutics Inc. (NASDAQ: SRPT) surged 38.89% in Tuesday pre-market following the U.S. Food and Drug ...

Nations that lead in clinical trials get earlier access to breakthrough therapies, shape global regulatory norms, and ...

Verona Pharma plc (NASDAQ:VRNA) is one of the best multibagger stocks according to hedge funds. On July 9, 2025, Merck & Co.

"This was primarily driven by 18% growth seen from the oncology portfolio, which has done well as a result of key drugs such ...

The FDA has lifted its hold on Elevidys for ambulatory patients, after asking Sarepta to pause the treatment following three deaths.

As reports surface about Elon Musk’s Boring Company planning a tunnel beneath Nashville, here’s a look at his existing ties to Tennessee.

Living Cell Technologies ( ($AU:1AI) ) has shared an announcement. Algorae Pharmaceuticals has announced significant advancements in its ...